Huapont Life Sciences Co Ltd (002004) — Financial Flexibility Index
Huapont Life Sciences Co Ltd (002004) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥795.22 Million (operating CF CN¥635.17 Million minus capex CN¥160.05 Million) represents 0% of total liabilities (CN¥13.15 Billion). Also explore Huapont Life Sciences Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Huapont Life Sciences Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Huapont Life Sciences Co Ltd across 24 annual periods. Check Huapont Life Sciences Co Ltd (002004) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for Huapont Life Sciences Co Ltd. For the full company profile including market capitalisation, see 002004 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥2.73 Billion | CN¥2.10 Billion | CN¥12.05 Billion | ▲ +22.9% |
| 2024 | 0.18x | CN¥2.58 Billion | CN¥1.63 Billion | CN¥13.98 Billion | ▼ -9.1% |
| 2023 | 0.20x | CN¥2.87 Billion | CN¥1.59 Billion | CN¥14.14 Billion | ▼ -22.6% |
| 2022 | 0.26x | CN¥3.54 Billion | CN¥2.41 Billion | CN¥13.47 Billion | ▲ +47.9% |
| 2021 | 0.18x | CN¥2.53 Billion | CN¥1.27 Billion | CN¥14.22 Billion | ▼ -30.6% |
| 2020 | 0.26x | CN¥3.60 Billion | CN¥2.37 Billion | CN¥14.09 Billion | ▼ -2.6% |
| 2019 | 0.26x | CN¥3.52 Billion | CN¥2.08 Billion | CN¥13.39 Billion | ▲ +20.4% |
| 2018 | 0.22x | CN¥3.01 Billion | CN¥1.91 Billion | CN¥13.80 Billion | ▲ +120.1% |
| 2017 | 0.10x | CN¥1.56 Billion | CN¥591.40 Million | CN¥15.79 Billion | ▲ +15.1% |
| 2016 | 0.09x | CN¥1.16 Billion | CN¥511.90 Million | CN¥13.52 Billion | ▼ -31.9% |
| 2015 | 0.13x | CN¥1.17 Billion | CN¥342.45 Million | CN¥9.30 Billion | ▼ -5.0% |
| 2014 | 0.13x | CN¥1.04 Billion | CN¥455.96 Million | CN¥7.84 Billion | ▼ -33.8% |
| 2013 | 0.20x | CN¥729.31 Million | CN¥349.51 Million | CN¥3.64 Billion | ▲ +3.8% |
| 2012 | 0.19x | CN¥572.96 Million | CN¥257.75 Million | CN¥2.97 Billion | ▲ +34.1% |
| 2011 | 0.14x | CN¥230.99 Million | CN¥135.23 Million | CN¥1.60 Billion | ▼ -66.0% |
| 2010 | 0.42x | CN¥136.71 Million | CN¥79.84 Million | CN¥322.58 Million | ▼ -47.1% |
| 2009 | 0.80x | CN¥196.99 Million | CN¥123.53 Million | CN¥245.68 Million | ▲ +26.4% |
| 2008 | 0.63x | CN¥206.25 Million | CN¥113.76 Million | CN¥325.26 Million | ▲ +11.6% |
| 2007 | 0.57x | CN¥203.23 Million | CN¥79.21 Million | CN¥357.78 Million | ▲ +20.8% |
| 2006 | 0.47x | CN¥113.87 Million | CN¥66.10 Million | CN¥242.18 Million | ▼ -80.2% |
| 2005 | 2.37x | CN¥88.12 Million | CN¥43.69 Million | CN¥37.17 Million | ▲ +93.2% |
| 2004 | 1.23x | CN¥97.43 Million | CN¥70.60 Million | CN¥79.39 Million | ▲ +12.2% |
| 2003 | 1.09x | CN¥87.50 Million | CN¥56.68 Million | CN¥79.99 Million | ▲ +28.1% |
| 2002 | 0.85x | CN¥89.59 Million | CN¥36.88 Million | CN¥104.91 Million | — |